
Guillermo (Gary) Tearney, MD, PhD, FACC, FCAP, FNAI
Dr. Gary Tearney is the Remondi Family Endowed MGH Research Institute Chair, Mike and Sue Hazard Family MGH Research Scholar 2012-2017, Professor of Pathology at Harvard Medical School, an Affiliated Faculty member of the Harvard-MIT Division of Health Sciences and Technology (HST) and leads the Tearney Lab at the Wellman Center for Photomedicine at Massachusetts General Hospital. Dr. Tearney received his MD magna cum laude from Harvard Medical School and his PhD in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology.
Dr. Tearney leads a team of 50+ who conduct research and collaborate across the Mass General Brigham and Boston ecosystem, as well as nationally and internationally, in the following areas: cancer, cardiology/vascular health, critical care, dermatology, gastroenterology, otolaryngology, pathology, pediatrics, primary care, pulmonology, radiology, and surgery. His specific research interests focus on developing and clinically validating non-invasive, high-resolution optical imaging methods for human disease diagnosis.
Dr. Tearneyโs lab was the first to perform human imaging in the coronary arteries and gastrointestinal tract in vivo with Optical Coherence Tomography (OCT), which provides cross-sectional images of tissue architectural microstructure at a resolution of 10 ยตm. An expert in OCT image interpretation, Dr. Tearney holds over 100 U.S. patents related to medical devices and was featured in MIT Technology Review in 2019 for his โgut probe pillโ, named a Top 10 Breakthrough Technology by Bill Gates. Dr. Tearney was recently named one of the nationโs Top Translational Researchers by Nature Biotechnology.
Dr. Tearney co-led the MGB Center for COVID Innovation (MGBCCI), launched to help coordinate, facilitate, and rapidly develop innovations for the most pressing COVID-19 issues affecting patients, frontline healthcare workers, and the community. He is a member of the Research Advisory Committee for the Marcus Institute for Aging Research at Hebrew Senior Life, founder of the College of American Pathologists In Vivo Microscopy Committee and the International Working Group on Intravascular OCT Standardization and Validation, groups that are dedicated to establishing standards to ensure the widespread adoption of innovative imaging technologies.